还没上市的RNA公司就被收购了。。

Bristol Myers Squibb has agreed to acquire privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash.

Orbital Therapeutics is advancing a new generation of RNA medicines designed to reprogram cells in vivo, treating diseases at their source. Its lead